TwinBeech Capital’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-84,870
Closed -$5.78M 703
2024
Q3
$5.78M Buy
+84,870
New +$4.79M 0.11% 213
2023
Q2
Sell
-277,213
Closed -$18.8M 678
2023
Q1
$18.8M Buy
+277,213
New +$17.8M 0.38% 75
2022
Q4
Sell
-366,558
Closed -$11.9M 761
2022
Q3
$11.9M Buy
+366,558
New +$15.1M 0.31% 97
2022
Q1
Sell
-14,687
Closed -$1.14M 573
2021
Q4
$1.14M Buy
+14,687
New +$1.3M 0.07% 324

Other funds holding EXAS

TwinBeech Capital's EXAS Position: Q4 2024 in Review

TwinBeech Capital sold out of Exact Sciences (EXAS) in Q4 2024, closing a stake of 84,870 shares — an estimated $5.78M sold.

TwinBeech Capital first reported a position in EXAS in Q4 2021 and held it in 4 quarters. The position peaked at $18.8M in Q1 2023. 592 funds tracked by Wall St. Rank hold EXAS as of Q4 2024.

  • TwinBeech Capital reported no remaining Exact Sciences position as of Q4 2024 after selling out during the quarter.
  • TwinBeech Capital sold 84,870 Exact Sciences shares in Q4 2024, an estimated $5.78M.
  • TwinBeech Capital first reported a position in Exact Sciences in Q4 2021 and held it in 4 quarters.
  • TwinBeech Capital's Exact Sciences position peaked at $18.8M in Q1 2023.
  • 592 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2024.

Based on TwinBeech Capital's 13F filing for Q4 2024, filed 14 Feb 2025.